| dc.contributor.author | O'Driscoll, Lorraine | en |
| dc.date.accessioned | 2016-07-19T10:21:26Z | |
| dc.date.available | 2016-07-19T10:21:26Z | |
| dc.date.issued | 2012 | en |
| dc.date.submitted | 2012 | en |
| dc.identifier.citation | Rani S, Germano S, Madden SF, Corcoran C, Breslin S, O'Brien NA, McDermott M, Browne B, O'Donovan N, Crown J, O'Driscoll L., Neuromedin U: A potential predictive biomarker for HER2-targeted drugs., J. Clin. Oncol., 30, 15, 2012, 617 - 617 | en |
| dc.identifier.other | Y | en |
| dc.description | PUBLISHED | en |
| dc.format.extent | 617 | en |
| dc.format.extent | 617 | en |
| dc.relation.ispartofseries | 30 | en |
| dc.relation.ispartofseries | 15 | en |
| dc.rights | Y | en |
| dc.title | Neuromedin U: A potential predictive biomarker for HER2-targeted drugs. | en |
| dc.title.alternative | J. Clin. Oncol. | en |
| dc.type | Published Abstract | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.identifier.peoplefinderurl | http://people.tcd.ie/lodrisc | en |
| dc.identifier.rssinternalid | 100742 | en |
| dc.identifier.doi | 10.1200/jco.2012.30.15_suppl.617 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.subject.TCDTheme | Cancer | en |
| dc.identifier.rssuri | http://meetinglibrary.asco.org/content/100396-114 | en |
| dc.identifier.orcid_id | 0000-0002-9860-8262 | en |
| dc.identifier.uri | http://hdl.handle.net/2262/76720 | |
